Autoimmune diseases are conditions in which the patient’s immune system generates antibody responses to tissues normally present in the body. This might be restricted to one organ or involve a particular tissue in different places. As a result of this immune response, damage to different organs occurs. Examples of autoimmune diseases that have responded to stem cell therapy include rheumatoid arthritis, multiple sclerosis, and lupus, scleroderma, diabetes type I and rheumatoid arthritis and many more.

Advantages of treating with allogeneic umbilical cord tissue-derived stem cells

  • Allogeneic stem cells can be administered multiple times over the course of days in uniform dosages that contain high cell counts.
  • The stem cells with the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration can be screened and selected.
  • Umbilical cord tissue provides an abundant supply of mesenchymal stem cells.
  • Mesenchymal stem cells are collected by liposuction
  • Since HUCT mesenchymal and autologous stem cells are not rejected and need no HLA typing.
  • There is a growing body of evidence showing that mesenchymal stem cells from umbilical cords are very robust.

Presently, autoimmune conditions are being treated with immune suppressive drugs such as steroids, methothrexate, cyclosporine, and more recently infliximab. Despite inducing temporary improvement, these drugs have long-term adverse side effects, and are also needed throughout life.

Stem cell therapy has shown promise in inducing profound healing activity in animals and humans in various forms of autoimmune disorders. Besides regenerating damaged tissues, stem cells have also the immune modulation properties and hence can restore the body’s ability to fight the disease. Stem cells and specifically, mesenchymal stem cells,home to inflamed /damaged tissue and start producing anti-inflammatory agents. These factors act locally and do not suppress the immune response of the patient’s whole body. Additionally, mesenchymal stem cells induce the production of T regulatory cells, a type of immune cell whose function is to protect the body against immunological self-attack.

A study on MSCs for rheumatoid arthritis (Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and Efficacy) showed that MSCs produced a significant decrease in pro-inflammatory cytokines IL-6 and TNF-α, both of which are temporarily targeted by many current RA treatments, – without the long-term side effects. These decreases are shown in Figure from the original publication.

Stem Cell Treatment: Autism Protocols

  • They are typically given intravenously (IV) over the course of a few days.

    Below is an example of a typical 4-day rheumatoid arthritis treatment protocol.

    • Medical evaluation and blood testing
    • Adipose derived stem cell and allogenic stem cells on day one
    • Five IV injections of allogeneic umbilical cord mesenchymal stem cells

    Your recommended protocol may differ from the example given above.

Proper follow-up helps us evaluate the effectiveness of our treatments and improve our treatment protocols based on observed outcomes. Therefore, one of our medical staff will contact you regularly to monitor your progress. You will be contacted after 1 month, 3 months, 4 months, and 1 year.

Your Name (required)

Your Email (required)

Phone (required)


Your Message